Apollo Hospitals, Singapore firm enhance AI-based tech for cardiac diseases

Move aimed to enable healthcare providers to predict risk of cardiac disease in patients and start intervention early

Apollo Hospitals announced a tie-up on Wednesday with Singapore-based ConnectedLife, leaders in the application of motor-state diagnostics, to integrate Apollo’s artificial intelligence-based web tool AICVD with ConnectedLife’s digital solutions for wellness, condition management and other health-focused applications.

The AICVD tool can predict the risk of cardiovascular disease. This will empower healthcare providers with the tools to predict the risk of cardiac disease in their patients and initiate intervention early enough to make a real difference.

The clinical integration was demonstrated during an online event to announce the collaboration. The cardiac risk scoring tool is useful for its speed in processing